| Year ended | Year ended | ||
| 31 March 2026 | 31 March 2025 | ||
Notes | £m | £m | |
Fee and other operating income | 3 | ||
Finance income | 5 | ||
Net gains on investments | 9 | ||
Total Revenue | |||
Other income | 8 | ||
Finance costs | 10 | ( | ( |
Administrative expenses | 11 | ( | ( |
Profit before tax | |||
Tax charge | 13 | ( | ( |
Profit for the year | |||
Attributable to: | |||
Equity holders of the parent | |||
Non-controlling interests | | | |
Earnings per share attributable to ordinary equity | |||
holders of the parent | |||
Basic (pence) | 15 | ||
Diluted (pence) | 15 |
| Year ended | Year ended | |
| 31 March 2026 | 31 March 2025 | |
Group | £m | £m |
Profit for the year | ||
Items that may be subsequently reclassified to profit or loss if specific conditions are met | ||
Exchange differences on translation of foreign operations | ( | |
Deferred tax on equity investments translation | ||
Total comprehensive income for the year | ||
Attributable to: | ||
Equity holders of the parent | ||
Non-controlling interests | ||
| 31 March 2026 | 31 March 2025 | ||
| Group | Group | ||
Notes | £m | £m | |
Non-current assets | |||
Intangible assets | 16 | ||
Property, plant and equipment | 17 | ||
Investment property | 18 | ||
Trade and other receivables | 19 | ||
Financial assets at fair value | 5 | ||
Deferred tax asset | 13 | ||
Current assets | |||
Trade and other receivables | 19 | ||
Current tax debtor | |||
Financial assets at fair value | 5 | ||
Derivative financial assets | 5 | ||
Cash and cash equivalents | 6 | ||
Total assets |
| 31 March 2026 | 31 March 2025 | ||
| Group | Group | ||
Notes | £m | £m | |
Non-current liabilities | |||
Trade and other payables | 20 | ||
Financial liabilities at fair value | 5, 7 | ||
Financial liabilities at amortised cost 1 | 7 | ||
Other financial liabilities 1 | 7 | ||
Deferred tax liabilities | 13 | ||
Current liabilities | |||
Trade and other payables | 20 | ||
Current tax creditor | |||
Financial liabilities at amortised cost 1 | 7 | ||
Other financial liabilities 1 | 7 | ||
Derivative financial liabilities | 5, 7 | ||
Total liabilities | |||
Equity and reserves | |||
Called up share capital | 22 | ||
Share premium account | 22 | ||
Other reserves | 22, 23 | ( | |
Retained earnings | |||
Equity attributable to owners of the Company | |||
Non-controlling interest | ( | ||
Total equity | |||
Total equity and liabilities |
| 31 March 2026 | 31 March 2025 | ||
| Group | Group | ||
Notes | £m | £m | |
Profit before tax from continuing operations | |||
Adjustments for non-cash items: | |||
Fee and other operating income | 3 | ( | ( |
Net investment returns | 9 | ( | ( |
Interest income | 8 | ( | ( |
Net fair value loss/(gain) on derivatives | ( | ||
Impact of movement in foreign exchange rates | ( | ||
Interest expense | 10 | ||
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 16, 17 | ||
Share-based payment expense | |||
Working capital changes: | |||
Decrease/(increase) in trade and other receivables | ( | ||
(Decrease)/increase in trade and other payables | ( | ||
( | ( | ||
Proceeds from sale of seed investments | |||
Purchase of seed investments | ( | ( | |
Purchase of investments | ( | ( | |
Proceeds from sales and maturities of investments | |||
Proceeds from borrowing related to seed investments | |||
Issuance of CLO notes | |||
Redemption of CLO notes | ( | ( | |
Interest received | |||
Dividends received | |||
Fee and other operating income received | |||
Interest paid | ( | ( | |
Cash flows generated from operations | |||
Taxes paid | ( | ( | |
Net cash flows from operating activities |
| 31 March 2026 | 31 March 2025 | ||
| Group | Group | ||
| Notes | £m | £m | |
Net cash flows from operating activities | |||
Investing activities | |||
Purchase of intangible assets | 16 | ( | ( |
Purchase of property, plant and equipment | 17 | ( | ( |
Net cash flow from derivative financial instruments | |||
Cash flow as a result of change in control of subsidiary | 30 | ||
Net cash flows from investing activities | |||
Financing activities | |||
Purchase of own shares | 23 | ( | ( |
Proceeds from shares issued | |||
Payment of principal portion of lease liabilities | 7 | ( | ( |
Repayment of borrowings | ( | ( | |
Dividends paid to equity holders of the parent | 14 | ( | ( |
Net cash flows used in financing activities | ( | ( | |
Net increase/(decrease) in cash and cash equivalents | ( | ||
Effects of exchange rate differences on cash and cash equivalents | ( | ||
Cash and cash equivalents at 1 April | 6 | ||
Cash and cash equivalents at 31 March | 6 |
| Other reserves | ||||||||||
| Share-based | Foreign | |||||||||
| Share | Share | Capital | payments | Own | currency | Non- | ||||
| capital | premium | redemption | reserve | shares | translation | Retained | controlling | Total | ||
| (note 22) | (note 22) | reserve | (note 24) | (note 23) | reserve 2 | earnings | Total | interests | equity | |
Group | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
Balance at | ( | ( | ||||||||
Profit after tax | ||||||||||
Exchange differences on translation of foreign operations | ||||||||||
Total comprehensive income for the year | ||||||||||
Issue of share capital | ||||||||||
Own shares acquired in the year - share scheme | ( | ( | ( | |||||||
Own shares acquired in the year - share buyback 3 | ( | ( | ( | |||||||
Options/awards exercised 1 | ( | ( | ( | ( | ||||||
Tax on options/awards exercised | ( | ( | ( | |||||||
Credit for equity settled share schemes | ||||||||||
Dividends paid (note 14) | ( | ( | ( | |||||||
Balance at | ( |
| Other reserves | ||||||||||
| Share-based | Foreign | |||||||||
| Share | Share | Capital | payments | Own | currency | Non- | ||||
| capital | premium | redemption | reserve | shares | translation | Retained | controlling | Total | ||
| (note 22) | (note 22) | reserve | (note 24) | (note 23) | reserve 2 | earnings | Total | interests | equity | |
Group | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
Balance at 1 April 2024 | ( | ( | ||||||||
Profit after tax | ||||||||||
Exchange differences on translation of foreign operations | ( | ( | ( | |||||||
Deferred tax on equity investments translation | ||||||||||
Total comprehensive income/(expense) for the year | ( | |||||||||
Adjustment of non-controlling interest on disposal of subsidiary | ( | ( | ||||||||
Issue of share capital | ||||||||||
Own shares acquired in the year - share scheme | ( | ( | ( | |||||||
Options/awards exercised 1 | ( | ( | ( | ( | ||||||
Tax on options/awards exercised | ||||||||||
Credit for equity settled share schemes | ||||||||||
Dividends paid (note 14) | ( | ( | ( | |||||||
Balance at 31 March 2025 | ( | ( |
| Accounting periods | ||
IFRS/IAS | commencing on or after | |
IFRS 9 | Amendment to IFRS 9 and IFRS 7 – Classification and | 1 January 2026 |
| Measurement of Financial Instruments | ||
IFRS 18 | Presentation and Disclosure in Financial Statements | 1 January 2027 |
IFRS 19 | Subsidiaries without Public Accountability: | 1 January 2027 |
| Disclosures |
| Year ended | Year ended | |
| 31 March 2026 | 31 March 2025 | |
Type of contract/service | £m | £m |
Management fees | 664.7 | 580.6 |
Performance-related management fees | 133.5 | 87.4 |
Other income | 5.9 | 8.0 |
Fee and other operating income | 804.1 | 676.0 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||||
| Reportable | Reportable | |||||
FMC | IC | segments | FMC | IC | segments | |
£m | £m | £m | £m | £m | £m | |
External fee income | 811.8 | — | 811.8 | 690.0 | — | 690.0 |
Inter-segmental fee | 23.3 | (23.3) | — | 24.6 | (24.6) | — |
Other operating income | 2.9 | 0.7 | 3.6 | 2.8 | 1.7 | 4.5 |
Fund management fee income | 838.0 | (22.6) | 815.4 | 717.4 | (22.9) | 694.5 |
Net investment returns | — | 98.2 | 98.2 | — | 192.5 | 192.5 |
Dividend income | 62.0 | — | 62.0 | 48.3 | — | 48.3 |
Finance gain | — | 20.4 | 20.4 | — | 8.3 | 8.3 |
Total revenue | 900.0 | 96.0 | 996.0 | 765.7 | 177.9 | 943.6 |
Interest income | 0.1 | 27.5 | 27.6 | 0.3 | 19.2 | 19.5 |
Interest expense | (2.3) | (33.1) | (35.4) | (2.5) | (39.6) | (42.1) |
Staff costs | (117.5) | (30.7) | (148.2) | (109.2) | (30.0) | (139.2) |
Incentive scheme costs | (129.4) | (28.3) | (157.7) | (128.8) | (29.5) | (158.3) |
Other administrative expenses | (64.1) | (32.0) | (96.1) | (64.1) | (27.2) | (91.3) |
Profit before tax | 586.8 | (0.6) | 586.2 | 461.4 | 70.8 | 532.2 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||||
| Reportable | Consolidated | Financial | Reportable | Consolidated | Financial | |
| segments | entities | statements | segments | entities | statements | |
£m | £m | £m | £m | £m | £m | |
Fund management fee income | 811.8 | (13.6) | 798.2 | 690.0 | (22.0) | 668.0 |
Other operating income | 3.6 | 2.3 | 5.9 | 4.5 | 3.5 | 8.0 |
Fee and other income | 815.4 | (11.3) | 804.1 | 694.5 | (18.5) | 676.0 |
Dividend income | 62.0 | (62.0) | — | 48.3 | (48.3) | — |
Finance gain | 20.4 | 2.0 | 22.4 | 8.3 | 1.9 | 10.2 |
Finance income/(loss) | 82.4 | (60.0) | 22.4 | 56.6 | (46.4) | 10.2 |
Net investment returns/gains on investments | 98.2 | 111.3 | 209.5 | 192.5 | 92.2 | 284.7 |
Total revenue | 996.0 | 40.0 | 1,036.0 | 943.6 | 27.3 | 970.9 |
Other income | 27.6 | 2.3 | 29.9 | 19.5 | — | 19.5 |
Finance costs | (35.4) | (4.2) | (39.6) | (42.1) | (1.6) | (43.7) |
Staff costs | (148.2) | — | (148.2) | (139.2) | — | (139.2) |
Incentive scheme costs | (157.7) | — | (157.7) | (158.3) | — | (158.3) |
Other administrative expenses | (96.1) | (36.1) | (132.2) | (91.3) | (27.4) | (118.7) |
Administrative expenses | (402.0) | (36.1) | (438.1) | (388.8) | (27.4) | (416.2) |
Profit before tax | 586.2 | 2.0 | 588.2 | 532.2 | (1.7) | 530.5 |
Tax charge | (108.2) | (1.3) | (109.5) | (79.8) | 0.5 | (79.3) |
Profit after tax | 478.0 | 0.7 | 478.7 | 452.4 | (1.2) | 451.2 |
2026 | 2025 | |||||
| Reportable | Consolidated | Financial | Reportable | Consolidated | Financial | |
| segments | entities | statements | segments | entities | statements | |
Year ended 31 March 2026 | £m | £m | £m | £m | £m | £m |
Non-current financial assets | 2,555.7 | 5,185.7 | 7,741.4 | 2,806.2 | 4,873.7 | 7,679.9 |
Other non-current assets | 217.4 | 131.4 | 348.8 | 150.0 | 123.5 | 273.5 |
Cash | 981.4 | 434.0 | 1,415.4 | 604.8 | 255.4 | 860.2 |
Current financial assets | 112.8 | (64.1) | 48.7 | 248.7 | (172.6) | 76.1 |
Other current assets | 264.4 | 93.5 | 357.9 | 270.2 | 182.7 | 452.9 |
Total assets | 4,131.7 | 5,780.5 | 9,912.2 | 4,079.9 | 5,262.7 | 9,342.6 |
Non-current financial liabilities 1 | 582.2 | 5,431.3 | 6,013.5 | 1,058.7 | 4,927.2 | 5,985.9 |
Other non-current liabilities | 76.9 | — | 76.9 | 54.2 | 2.8 | 57.0 |
Current financial liabilities 1 | 534.2 | 25.1 | 559.3 | 199.8 | (2.4) | 197.4 |
Other current liabilities | 234.1 | 327.4 | 561.5 | 271.2 | 340.2 | 611.4 |
Total liabilities | 1,427.4 | 5,783.8 | 7,211.2 | 1,583.9 | 5,267.8 | 6,851.7 |
Equity | 2,704.3 | (3.3) | 2,701.0 | 2,496.0 | (5.1) | 2,490.9 |
Total equity and liabilities | 4,131.7 | 5,780.5 | 9,912.2 | 4,079.9 | 5,262.7 | 9,342.6 |
| 2026 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Profit before tax from continuing operations | 586.2 | 2.0 | 588.2 |
Adjustments for non-cash items: | |||
Fee and other operating (income)/expense | (815.4) | 11.3 | (804.1) |
Net investment returns | (98.2) | (111.3) | (209.5) |
Net fair value (loss)/gain on derivatives | 9.2 | (1.4) | 7.8 |
Impact of movement in foreign exchange rates | (29.6) | (0.6) | (30.2) |
Dividend income | (62.0) | 62.0 | — |
Interest income | (27.6) | (2.3) | (29.9) |
Interest expense | 35.5 | 4.1 | 39.6 |
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 17.2 | — | 17.2 |
Share-based payment expense | 45.0 | — | 45.0 |
Working capital changes: | |||
(Increase)/decrease in trade receivables | (0.2) | 110.5 | 110.3 |
Decrease in trade and other payables | (47.8) | (133.3) | (181.1) |
(387.7) | (59.0) | (446.7) | |
Proceeds from sale of seed investments | 186.3 | — | 186.3 |
Purchase of seed investments | (156.4) | — | (156.4) |
Purchase of investments | (259.5) | (2,109.2) | (2,368.7) |
Proceeds from sales and maturities of investments | 636.2 | 2,575.2 | 3,211.4 |
Proceeds from borrowing related to seed investments | — | 87.2 | 87.2 |
Issuance of CLO notes | — | 724.8 | 724.8 |
Redemption of CLO notes | — | (1,244.1) | (1,244.1) |
Interest and dividend income received | 195.2 | 361.6 | 556.8 |
Fee and other operating income received | 754.5 | (5.8) | 748.7 |
Interest paid | (34.3) | (323.9) | (358.2) |
Cash flow generated from operations | 934.3 | 6.8 | 941.1 |
Taxes paid | (95.0) | — | (95.0) |
Net cash flows from operating activities | 839.3 | 6.8 | 846.1 |
| 2026 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Net cash flows from operating activities | 839.3 | 6.8 | 846.1 |
Investing activities | |||
Purchase of intangible assets | (6.6) | — | (6.6) |
Purchase of property, plant and equipment | (0.7) | — | (0.7) |
Net cash flow from derivative financial instruments | 20.6 | 1.3 | 21.9 |
Cash flow as a result of change in control of subsidiary | — | 167.6 | 167.6 |
Net cash flows from investing activities | 13.3 | 168.9 | 182.2 |
Financing activities | |||
Purchase of Own Shares | (78.0) | — | (78.0) |
Proceeds from shares issued | 27.1 | — | 27.1 |
Payment of principal portion of lease liabilities | (12.5) | — | (12.5) |
Repayment of borrowings | (172.4) | — | (172.4) |
Dividends paid to equity holders of the parent | (242.3) | — | (242.3) |
Net cash flows used in financing activities | (478.1) | — | (478.1) |
Net increase in cash and cash equivalents | 374.5 | 175.7 | 550.2 |
Effects of exchange rate differences on cash and cash equivalents | 2.1 | 2.9 | 5.0 |
Cash and cash equivalents at 1 April | 604.8 | 255.4 | 860.2 |
Cash and cash equivalents at 31 March | 981.4 | 434.0 | 1,415.4 |
| 2025 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Profit/(loss) before tax from continuing operations | 532.2 | (1.7) | 530.5 |
Adjustments for non-cash items: | |||
Fee and other operating (income)/expense | (694.4) | 18.4 | (676.0) |
Net investment returns | (192.5) | (92.2) | (284.7) |
Net fair value gain on derivatives | (38.4) | — | (38.4) |
Impact of movement in foreign exchange rates | 30.1 | (2.0) | 28.1 |
Dividend income | (48.3) | 48.3 | — |
Interest income | (19.5) | — | (19.5) |
Interest expense | 42.1 | 1.6 | 43.7 |
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 17.8 | — | 17.8 |
Share-based payment expense | 45.6 | — | 45.6 |
Working capital changes: | |||
Decrease/(increase) in trade receivables | 29.9 | (117.5) | (87.6) |
(Decrease)/increase in trade and other payables | (27.2) | 39.5 | 12.3 |
(322.6) | (105.6) | (428.2) | |
Proceeds from sale of seed investments | 285.6 | — | 285.6 |
Purchase of seed investments | (165.9) | — | (165.9) |
Purchase of investments | (519.7) | (2,440.9) | (2,960.6) |
Proceeds from sales and maturities of investments | 500.3 | 2,617.1 | 3,117.4 |
Proceeds from borrowing related to seed investments | — | 47.4 | 47.4 |
Issuance of CLO notes | — | 577.0 | 577.0 |
Redemption of CLO notes | — | (1,085.0) | (1,085.0) |
Interest and dividend income received | 172.0 | 392.4 | 564.4 |
Fee and other operating income received | 656.1 | 7.2 | 663.3 |
Interest paid | (41.2) | (369.7) | (410.9) |
Cash flow generated from/(used in) operations | 564.6 | (360.1) | 204.5 |
Taxes paid | (68.4) | — | (68.4) |
Net cash flows from/(used in) operating activities | 496.2 | (360.1) | 136.1 |
| 2025 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Net cash flows from/(used in) operating activities | 496.2 | (360.1) | 136.1 |
Investing activities | |||
Purchase of intangible assets | (5.9) | — | (5.9) |
Purchase of property, plant and equipment | (0.7) | — | (0.7) |
Net cash flow from derivative financial instruments | 22.4 | — | 22.4 |
Cash flow as a result of change in control of subsidiary | — | 260.3 | 260.3 |
Net cash flows from investing activities | 15.8 | 260.3 | 276.1 |
Financing activities | |||
Purchase of Own Shares | (42.4) | — | (42.4) |
Payment of principal portion of lease liabilities | (12.2) | — | (12.2) |
Repayment of borrowings | (241.1) | — | (241.1) |
Dividends paid to equity holders of the parent | (228.9) | — | (228.9) |
Net cash flows used in financing activities | (524.6) | — | (524.6) |
Net decrease in cash and cash equivalents | (12.6) | (99.8) | (112.4) |
Effects of exchange rate differences on cash and cash equivalents | (9.8) | (7.6) | (17.4) |
Cash and cash equivalents at 1 April | 627.2 | 362.8 | 990.0 |
Cash and cash equivalents at 31 March | 604.8 | 255.4 | 860.2 |
2026 | 2025* | |
Asset Analysis by Geography | £m | £m |
Europe (including UK) | 150.4 | 117.5 |
Asia Pacific | 134.6 | 127.1 |
North America | 63.8 | 28.9 |
Total | 348.8 | 273.5 |
2026 | 2025* | |
Income Analysis by Geography | £m | £m |
Europe (including UK) | 765.2 | 746.3 |
Asia Pacific | 5.2 | 4.4 |
North America | 265.6 | 220.2 |
Total | 1,036.0 | 970.9 |
As at 31 March 2026 | As at 31 March 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Financial assets | ||||||||
Investment in or alongside managed funds 1 | 3.7 | 0.3 | 2,152.3 | 2,156.3 | 3.7 | 2.3 | 2,417.4 | 2,423.4 |
Collateral assets held in consolidated CLOs | — | 4,826.7 | 542.4 | 5,369.1 | — | 4,533.1 | 443.2 | 4,976.3 |
Derivative assets | — | 4.9 | — | 4.9 | — | 26.3 | — | 26.3 |
Investment in private companies 2 | — | — | 150.1 | 150.1 | — | — | 210.8 | 210.8 |
Investment in public companies | 11.9 | — | — | 11.9 | 4.3 | — | — | 4.3 |
Investments in unconsolidated CLOs | — | 79.7 | 18.1 | 97.8 | — | 86.1 | 28.8 | 114.9 |
Total financial assets 3 | 15.6 | 4,911.6 | 2,862.9 | 7,790.1 | 8.0 | 4,647.8 | 3,100.2 | 7,756.0 |
Financial liabilities | ||||||||
Liabilities of consolidated CLOs | — | (5,298.1) | (5.7) | (5,303.8) | — | (4,560.3) | (297.9) | (4,858.2) |
Derivative liabilities | — | (16.1) | — | (16.1) | — | (8.3) | — | (8.3) |
Total financial liabilities 4 | — | (5,314.2) | (5.7) | (5,319.9) | — | (4,568.6) | (297.9) | (4,866.5) |
As at 31 March 2026 | As at 31 March 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
Company | £m | £m | £m | £m | £m | £m | £m | £m |
Financial Assets | ||||||||
Investment in or alongside managed funds | 3.7 | — | 69.4 | 73.1 | 3.6 | — | 102.0 | 105.6 |
Derivative assets | — | 4.9 | — | 4.9 | — | 26.3 | — | 26.3 |
Investment in private & public companies | 1.3 | — | 22.1 | 23.4 | 2.3 | — | 77.1 | 79.4 |
Investments in unconsolidated CLOs and credit funds | — | — | 19.8 | 19.8 | — | — | — | — |
Total assets | 5.0 | 4.9 | 111.3 | 121.2 | 5.9 | 26.3 | 179.1 | 211.3 |
Financial Liabilities | ||||||||
Derivative liabilities | — | 18.0 | — | 18.0 | — | 10.6 | — | 10.6 |
Total liabilities | — | 18.0 | — | 18.0 | — | 10.6 | — | 10.6 |
| Investment in | |||||
| Investment in or | loans held in | Investment in | Investments in | ||
| alongside | consolidated | private | unconsolidated | ||
| managed funds | entities | companies | CLOs | Total | |
Group | £m | £m | £m | £m | £m |
At 1 April 2025 | 2,417.4 | 443.2 | 210.8 | 28.8 | 3,100.2 |
Total gains or losses in the income statement | |||||
– Net investment return 2 | 164.3 | (17.5) | (10.2) | 1.9 | 138.5 |
– Foreign exchange | 49.0 | (4.2) | (5.4) | 0.8 | 40.2 |
Purchases | 280.5 | 331.4 | 36.4 | 65.3 | 713.6 |
Exit proceeds | (722.4) | (215.3) | (118.0) | (78.7) | (1,134.4) |
Transfers in 1 | — | 118.8 | — | — | 118.8 |
Transfers out 1 | — | (114.0) | — | — | (114.0) |
Reclassification 3 | (36.5) | — | 36.5 | — | — |
At 31 March 2026 | 2,152.3 | 542.4 | 150.1 | 18.1 | 2,862.9 |
| Investment in | |||||
| Investment in or | loans held in | Investment in | Subordinated | ||
| alongside | consolidated | private | notes of CLO | ||
| managed funds | entities | companies | vehicles | Total | |
Group | £m | £m | £m | £m | £m |
At 1 April 2024 | 2,300.7 | 462.6 | 401.7 | 19.7 | 3,184.7 |
| Total gains or losses in the income statement | |||||
– Net investment return 2 | 177.1 | 16.1 | 30.1 | (1.3) | 222.0 |
– Foreign exchange | (41.8) | (10.0) | (10.1) | (0.2) | (62.1) |
Purchases | 534.7 | 319.5 | 4.8 | 37.3 | 896.3 |
Exit proceeds | (565.4) | (233.2) | (203.6) | (26.7) | (1,028.9) |
Transfers in 1 | — | 42.7 | — | — | 42.7 |
Transfers out 1 | — | (154.5) | — | — | (154.5) |
Reclassification 3 | 12.1 | — | (12.1) | — | — |
At 31 March 2025 | 2,417.4 | 443.2 | 210.8 | 28.8 | 3,100.2 |
2026 | 2025 | |||||||
| Investment in or | Investment in | Subordinated | Investment in or | Investment in | Subordinated | |||
| alongside | private | notes of CLO | alongside | private | notes of CLO | |||
| managed funds | companies | vehicles | Total | managed funds | companies | vehicles | Total | |
Company | £m | £m | £m | £m | £m | £m | £m | £m |
At 1 April | 102.0 | 77.1 | — | 179.1 | 128.4 | 87.1 | 21.8 | 237.3 |
Total gains or losses in the income statement | ||||||||
– Net investment return | (0.5) | (0.1) | (0.6) | (1.2) | 5.3 | (2.9) | 1.3 | 3.7 |
– Foreign exchange | (9.4) | (1.0) | 0.2 | (10.2) | (2.1) | (2.9) | (0.6) | (5.6) |
Purchases | 7.3 | 0.3 | 20.2 | 27.8 | 20.8 | 3.7 | — | 24.5 |
Exit proceeds | (30.0) | (54.2) | — | (84.2) | (50.4) | (7.9) | (22.5) | (80.8) |
At 31 March | 69.4 | 22.1 | 19.8 | 111.3 | 102.0 | 77.1 | — | 179.1 |
2026 | 2025 | |
| Financial | Financial | |
| liabilities | liabilities | |
| designated as | designated as | |
| FVTPL | FVTPL | |
Group | £m | £m |
At 1 April | 297.9 | 186.7 |
Total gains or losses in the income statement | ||
– Fair value (gains)/losses | (332.0) | 10.6 |
– Foreign exchange (gains)/losses | 4.7 | (3.9) |
Purchases | 96.1 | 68.9 |
Transfer between levels | (61.0) | 35.6 |
At 31 March | 5.7 | 297.9 |
Fair Value | Fair Value | 31 March 2026 | Effect on Fair | 31 March 2025 | Effect on Fair | ||||||
Group assets | As at | As at | Weighted | Value | Weighted | Value | |||||
| 31 March 2026 | 31 March 2025 | Key Unobservable | Average/ Fair | Sensitivity/ | 31 March 2026 | Average/ Fair | 31 March 2025 | ||||
Primary Valuation Techniques 1 | Inputs | Range | Value Inputs | Scenarios | Range | Value Inputs | |||||
£m | £m | £m | £m | ||||||||
Structured Capital & Secondaries: | 1,098.8 | 1,466.9 | Market comparable companies | Earnings multiple | 8.0x - 25.0x | 14.4x | +10% Earnings multiple³ | 116.7 | 7.5x – 27.5x | 14.0x | 135.2 |
Corporate Investments | Discounted cash flow | Discount rate | 7.6% - 20.7% | 10.2% | -10% Earnings multiple³ | (116.7) | 7.6% - 20.9% | 10.6 % | (138.8) | ||
| calibrated to market | |||||||||||
comparable companies 2 | Earnings multiple | 9.2x - 20.4x | 13.6x | 4.9x – 23.1x | 13.3x | ||||||
Structured Capital & Secondaries: | 687.6 | 537.4 | Third-party valuation / funding | N/A | N/A | N/A | +10% valuation | 68.8 | N/A | N/A | 53.7 |
Strategic Equity, LP Secondaries, Recovery Fund, Life Sciences, CPE | round value | -10% valuation | (68.8) | N/A | N/A | (53.7) | |||||
Seed Investments | 44.1 | 120.8 | Various | +10% valuation | 4.4 | 12.1 | |||||
| -10% valuation | (4.4) | (12.1) | |||||||||
Debt: Private Debt: North | 58.0 | 65.7 | Market comparable companies | Earnings multiple | 7.5x - 17.8x | 14.1x | +10% Earnings multiple³ | 4.7 | 9.5x – 21.0x | 14.3x | 5.9 |
American Credit Partners | -10% Earnings multiple³ | (4.4) | (5.9) | ||||||||
Debt: Private Debt: Senior Debt | 41.2 | 42.3 | Probability of default | 0.7%-1.9% | 0.9% | Upside case | — | 0.8%-2.1% | 1.0 % | — | |
Partners | Amortised Cost with ECL | Loss given default | 35.6 % | 35.6% | Downside case | (0.2) | 36.0 % | 36.0 % | (0.3) | ||
| Impairment assessment | Maturity of loan | 3 years | 3 years | 3 years | 3 years | ||||||
Effective interest rate | 10.1%-10.3% | 10.2% | 9.7%-9.8% | 9.8 % | |||||||
Debt: Credit: Non-consolidated | 4.4 | 7.7 | Discount rate | 7.5%-59.0% | 17.0% | 10.5% - 38.5% | 20.0 % | ||||
CLOs and credit funds | Third-party valuation: | Default rate | 2.0% | 2.0% | Upside case 4 | 29.6 | 2.0 % | 2.0 % | 21.6 | ||
| Discounted cash flow | Prepayment rate % | 18.7%-20.0% | 19.7% | Downside case 4 | (31.2) | 15.0%-25.0% | 21.0 % | (19.9) | |||
Recovery rate % | 65.0% | 65.0% | 65.0 % | 65.0 % | |||||||
Reinvestment price | 99.4%-99.5% | 99.5% | 99.0%-99.5% | 99.4 % | |||||||
Debt: Credit: Consolidated CLOs | 542.4 | 443.2 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 54.2 | N/A | N/A | 44.3 |
| -10% Third-party valuation | (54.2) | (44.3) | |||||||||
Debt: Credit: Liquid Funds | 29.8 | 31.4 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 3.0 | N/A | N/A | 3.1 |
| -10% Third-party valuation | (3.0) | (3.1) | |||||||||
Real Assets | 356.6 | 384.8 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 35.7 | N/A | N/A | 38.5 |
LTV-based impairment model | N/A | N/A | N/A | -10% Third-party valuation | (35.7) | N/A | N/A | (38.5) | |||
Total financial assets | 2,862.9 | 3,100.2 | Total Upside sensitivity | 248.3 | 314.4 | ||||||
| Total Downside sensitivity | (249.8) | (316.6) | |||||||||
Liabilities of Consolidated CLOs | (5.7) | (297.9) | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | (0.6) | N/A | N/A | (29.8) |
and credit funds | -10% Third-party valuation | 0.6 | N/A | N/A | 29.8 | ||||||
Total financial liabilities | (5.7) | (297.9) |
2026 | 2025 | |||||
| Contract or | Fair values | Contract or | Fair values | |||
| underlying | underlying | |||||
| principal amount | Asset | Liability | principal amount | Asset | Liability | |
Group | £m | £m | £m | £m | £m | £m |
Cross currency swaps | — | — | — | 100.6 | 3.9 | (6.1) |
Foreign exchange forward contracts and swaps | 1,715.4 | 4.9 | (16.1) | 1,592.4 | 22.4 | (2.2) |
Total | 1,715.4 | 4.9 | (16.1) | 1,693.0 | 26.3 | (8.3) |
2026 | 2025 | |||||
| Contract or | Contract or | |||||
| underlying | Fair values | underlying | Fair values | |||
| principal amount | Asset | Liability | principal amount | Asset | Liability | |
Company | £m | £m | £m | £m | £m | £m |
Cross currency swaps | — | — | — | 100.6 | 3.9 | (6.1) |
Foreign exchange forward contracts and swaps | 1,766.5 | 4.9 | (18.0) | 1,552.0 | 22.4 | (4.5) |
Total | 1,766.5 | 4.9 | (18.0) | 1,652.6 | 26.3 | (10.6) |
Group | Company | |||
2026 | 2025 | 2026 | 2025 | |
£m | £m | £m | £m | |
Cash and cash equivalents | ||||
Cash at bank and in hand | 1,415.4 | 860.2 | 832.5 | 433.1 |
2026 | 2025 (restated) 1 | |||||
| Interest rate | Current | Non-current | Current | Non-current | ||
Group | % | Maturity | £m | £m | £m | £m |
Liabilities held at amortised cost | ||||||
– Private placement | 3.04% - 5.35% | 2026 - 2029 | 66.8 | 94.4 | 177.4 | 163.2 |
– Listed notes and bonds | 1.63% - 2.50% | 2027 - 2030 | 439.0 | 434.7 | 2.3 | 834.4 |
– Unsecured bank debt 2 | SONIA +1.05% | 2028 | (0.2) | (0.9) | (0.4) | (1.0) |
Total Liabilities held at amortised cost | 505.6 | 528.2 | 179.3 | 996.6 | ||
Lease liabilities | 2.80% - 7.09% | 2026 - 2034 | 10.6 | 54.1 | 9.8 | 62.1 |
Borrowings related to seed investments | 1.72% - 6.20% | 2026 - 2029 | 27.0 | 127.4 | — | 69.0 |
Liabilities held at FVTPL: | ||||||
– Derivative financial liabilities | 16.1 | — | 8.3 | — | ||
– Structured entities controlled by the Group 3 | 0.65% - 9.58% | 2030 - 2039 | — | 5,303.8 | — | 4,858.2 |
559.3 | 6,013.5 | 197.4 | 5,985.9 |
2026 | 2025 (restated) 1 | |||||
| Interest rate | Current | Non-current | Current | Non-current | ||
Company | % | Maturity | £m | £m | £m | £m |
Liabilities held at amortised cost | ||||||
– Private placement | 3.04% - 5.35% | 2026 - 2029 | 66.8 | 94.4 | 177.4 | 163.2 |
– Listed notes and bonds | 1.63% - 2.50% | 2027 - 2030 | 439.0 | 434.7 | 2.3 | 834.4 |
– Unsecured bank debt 2 | SONIA +1.05% | 2028 | (0.2) | (0.9) | (0.4) | (1.0) |
Total Liabilities held at amortised cost | 505.6 | 528.2 | 179.3 | 996.6 | ||
Lease liabilities | 3.60% | 2026 - 2031 | 4.7 | 25.7 | 4.5 | 30.2 |
Liabilities held at FVTPL | ||||||
– Derivative financial liabilities | 18.0 | — | 10.6 | — | ||
528.3 | 553.9 | 194.4 | 1,026.8 |
Group | Company | |||
2026 | 2025 | 2026 | 2025 | |
£m | £m | £m | £m | |
At 1 April | 1,247.8 | 1,525.6 | 1,210.6 | 1,486.7 |
Repayment of long term borrowings | (172.4) | (241.1) | (172.4) | (241.1) |
Payment of principal portion of lease liabilities | (12.5) | (12.2) | (5.7) | (6.0) |
Establishment of lease liability | 3.5 | 4.6 | 0.1 | — |
Net interest movement | 1.1 | (0.1) | 1.2 | (1.6) |
Foreign exchange movement | 31.0 | (29.0) | 30.4 | (27.4) |
At 31 March | 1,098.5 | 1,247.8 | 1,064.2 | 1,210.6 |
2026 | 2025 | |
£m | £m | |
Interest income on cash deposits | 29.9 | 19.5 |
29.9 | 19.5 |
2026 | 2025 | |
£m | £m | |
Financial assets | ||
Change in fair value of financial instruments mandatorily at FVTPL | 189.1 | 644.6 |
Financial liabilities | ||
Change in fair value of financial instruments designated at FVTPL | 20.4 | (359.9) |
Net gains arising on investments | 209.5 | 284.7 |
2026 | 2025 | |
Finance costs | £m | £m |
Interest expense recognised on financial liabilities held at amortised cost | 33.9 | 36.5 |
Arrangement and commitment fees | 3.5 | 4.7 |
Interest expense associated with lease obligations | 2.2 | 2.5 |
39.6 | 43.7 |
2026 | 2025 | |
£m | £m | |
Staff costs | 305.9 | 297.4 |
Amortisation and depreciation | 17.1 | 17.8 |
Operating lease expenses | 2.6 | 3.7 |
Auditor's remuneration | 2.8 | 2.7 |
2026 | 2025 | |
£m | £m | |
ICG Group | ||
Audit fees | ||
Group audit of the annual accounts | 1.8 | 1.8 |
Audit of subsidiaries' annual accounts | 0.4 | 0.4 |
Audit of controlled CLOs | 0.2 | 0.1 |
Total audit fees | 2.4 | 2.3 |
Non-audit fees | ||
Audit-related assurance services | 0.2 | 0.2 |
Other assurance services | 0.2 | 0.2 |
Total non-audit fees | 0.4 | 0.4 |
Total auditor's remuneration incurred by the Group | 2.8 | 2.7 |
2026 | 2025 | |
£m | £m | |
Directors’ emoluments | 5.6 | 5.2 |
Employee costs during the year including Directors: | ||
Wages and salaries | 262.4 | 256.2 |
Social security costs | 32.9 | 31.1 |
Pension costs | 10.6 | 10.1 |
Total employee costs (note 11) | 305.9 | 297.4 |
The monthly average number of employees (including Executive Directors) was: | ||
Investment Executives | 314 | 317 |
Marketing and support functions | 395 | 375 |
Executive Directors | 3 | 3 |
695 |
2026 | 2025 | |
£m | £m | |
Current tax: | ||
Current year | 83.0 | 108.0 |
Foreign tax suffered | 0.5 | — |
Prior year adjustment | 7.2 | (12.7) |
90.7 | 95.3 | |
Deferred tax: | ||
Current year | 17.5 | (21.6) |
Prior year adjustment | 1.3 | 5.6 |
18.8 | (16.0) | |
Tax on profit on ordinary activities | 109.5 | 79.3 |
2026 | 2025 | |
£m | £m | |
Profit on ordinary activities before tax | 588.2 | 530.5 |
Tax at 25% (2025:25%) | 147.1 | 132.6 |
Effects of Prior year adjustment to current tax | 7.2 | (12.7) |
Prior year adjustment to deferred tax | 1.3 | 5.6 |
155.6 | 125.5 | |
Non-taxable and non-deductible items | 4.3 | 3.1 |
Non-taxable investment company income | (54.0) | (38.1) |
Trading income generated by overseas subsidiaries subject to different tax rates | 4.1 | (11.1) |
Effect of change in statutory tax rate | (1.3) | — |
FX adjustment | 0.8 | (0.1) |
Tax charge for the period | 109.5 | 79.3 |
| Share-based | |||||
| payments and | |||||
| compensation | Tax losses | Other | |||
| deductible as | carried | temporary | |||
Deferred tax (asset)/liability | Investments | paid | forward | differences | Total |
Group | £m | £m | £m | £m | £m |
As at 31 March 2024 | 47.2 | (51.5) | (7.3) | (2.4) | (14.0) |
Prior year adjustment | 2.1 | — | 1.7 | 1.9 | 5.7 |
Charge/(credit) to equity | (1.1) | 2.3 | — | — | 1.3 |
Charge/(credit) to income | (14.7) | 2.0 | (3.1) | (5.7) | (21.6) |
Movement in foreign exchange on retranslation | (0.8) | — | 0.2 | 0.3 | (0.3) |
As at 31 March 2025 | 32.7 | (47.1) | (8.5) | (5.9) | (28.9) |
Prior year adjustment | 2.6 | — | — | (1.3) | 1.3 |
Charge/(credit) to equity | — | 3.4 | — | — | 3.4 |
Charge/(credit) to income | 6.4 | 7.3 | (3.0) | 6.8 | 17.5 |
Movement in foreign exchange on retranslation | (0.5) | 0.1 | 0.1 | 0.1 | (0.2) |
As at 31 March 2026 | 41.2 | (36.3) | (11.4) | (0.3) | (6.9) |
| Share based | |||||
| payments and | |||||
| compensation | Other | ||||
| deductible as | temporary | ||||
Deferred tax (asset)/liability | Investments | paid | Derivatives | differences | Total |
Company | £m | £m | £m | £m | £m |
As at 31 March 2024 | 6.3 | — | 0.9 | 0.5 | 7.7 |
Prior year adjustment | (0.9) | 0.0 | — | (0.3) | (1.2) |
Charge/(credit) to income | (1.7) | — | (0.7) | (0.4) | (2.7) |
As at 31 March 2025 | 3.7 | — | 0.2 | (0.2) | 3.7 |
Prior year adjustment | — | — | — | — | — |
Charge/(credit) to income | (2.4) | — | (0.2) | 3.1 | 0.5 |
As at 31 March 2026 | 1.3 | — | — | 2.9 | 4.2 |
2026 | 2025 | |||
| Per share | Per share | |||
pence | £m | pence | £m | |
Ordinary dividends paid | ||||
Final | 56.7 | 162.8 | 53.2 | 153.3 |
Interim | 27.7 | 79.5 | 26.3 | 75.6 |
84.4 | 242.3 | 79.5 | 228.9 | |
Proposed final dividend | 169.1 | 56.7 | 162.8 | |
Total dividend for the financial year ended 31 March | 87.0 | 248.6 | 83.0 | 238.4 |
| Year ended | Year ended | |
| 31 March 2026 | 31 March 2025 | |
Earnings | £m | £m |
Earnings for the purposes of basic and diluted earnings per share being net | 478.4 | 451.2 |
profit attributable to equity holders of the Parent | ||
Number of shares | ||
Weighted average number of ordinary shares for the purposes of basic | 286,779,584 | 287,221,959 |
earnings per share | ||
Effect of dilutive potential ordinary share options | 5,086,405 | 6,176,750 |
Weighted average number of ordinary shares for the purposes of diluted | 291,865,989 | 293,398,709 |
earnings per share | ||
Earnings per share | ||
Basic, profit attributable to equity holders of the parent (pence) | 166.8p | 157.1p |
Diluted, profit attributable to equity holders of the parent (pence) | 163.9p | 153.8p |
Computer software | Goodwill 1 | Investment management contracts | Total | |||||
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 23.2 | 17.9 | 4.3 | 4.3 | 1.1 | 1.1 | 28.6 | 23.3 |
Reclassified 2 | — | (0.6) | — | — | — | — | — | (0.6) |
Additions | 6.6 | 5.9 | — | — | — | — | 6.6 | 5.9 |
At 31 March | 29.8 | 23.2 | 4.3 | 4.3 | 1.1 | 1.1 | 35.2 | 28.6 |
Amortisation | ||||||||
At 1 April | 11.9 | 7.3 | — | — | 1.1 | 1.0 | 13.0 | 8.3 |
Charge for the year | 4.5 | 4.6 | — | — | — | 0.1 | 4.5 | 4.7 |
At 31 March | 16.4 | 11.9 | — | — | 1.1 | 1.1 | 17.5 | 13.0 |
Net book value | 13.4 | 11.3 | 4.3 | 4.3 | — | — | 17.7 | 15.6 |
| Computer software | ||
2026 | 2025 | |
Company | £m | £m |
Cost | ||
At 1 April | 22.4 | 17.1 |
Additions | 7.2 | 5.3 |
At 31 March | 29.6 | 22.4 |
Amortisation | ||
At 1 April | 11.8 | 7.4 |
Charge for the year | 4.5 | 4.4 |
At 31 March | 16.3 | 11.8 |
Net book value | 13.3 | 10.6 |
Furniture and equipment | ROU asset | Leasehold improvements | Total | |||||
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 6.8 | 5.9 | 92.7 | 89.1 | 16.9 | 16.8 | 116.4 | 111.8 |
Reclassified 1 | — | 0.6 | — | — | — | — | — | 0.6 |
Additions | 0.7 | 0.4 | 3.5 | 4.6 | — | 0.3 | 4.2 | 5.3 |
Disposals | — | — | (0.4) | — | — | — | (0.4) | — |
Exchange differences | — | (0.1) | (0.2) | (1.0) | (0.1) | (0.2) | (0.3) | (1.3) |
At 31 March | 7.5 | 6.8 | 95.6 | 92.7 | 16.8 | 16.9 | 119.9 | 116.4 |
Depreciation | ||||||||
At 1 April | 5.0 | 2.8 | 35.0 | 25.7 | 5.7 | 4.1 | 45.7 | 32.6 |
Charge for the year | 1.4 | 2.2 | 9.7 | 9.3 | 1.6 | 1.6 | 12.7 | 13.1 |
Disposals | — | — | (0.2) | — | — | — | (0.2) | — |
Exchange differences | — | — | 0.2 | — | — | — | 0.2 | — |
At 31 March | 6.4 | 5.0 | 44.7 | 35.0 | 7.3 | 5.7 | 58.4 | 45.7 |
Net book value | 1.1 | 1.8 | 50.9 | 57.7 | 9.5 | 11.2 | 61.5 | 70.7 |
Furniture and equipment | ROU asset | Leasehold improvements | Total | |||||
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
Company | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 1.3 | 1.1 | 47.5 | 47.5 | 10.2 | 10.2 | 59.0 | 58.8 |
Additions | 0.2 | 0.2 | 0.1 | — | — | — | 0.3 | 0.2 |
At 31 March | 1.5 | 1.3 | 47.6 | 47.5 | 10.2 | 10.2 | 59.3 | 59.0 |
Depreciation | ||||||||
At 1 April | 0.8 | 0.5 | 20.3 | 16.4 | 3.9 | 2.9 | 25.0 | 19.8 |
Charge for the year | 0.3 | 0.3 | 4.1 | 3.9 | 0.9 | 1.0 | 5.3 | 5.2 |
At 31 March | 1.1 | 0.8 | 24.4 | 20.3 | 4.8 | 3.9 | 30.3 | 25.0 |
Net book value | 0.4 | 0.5 | 23.2 | 27.2 | 5.4 | 6.3 | 29.0 | 34.0 |
| 2026 | 2025 | |
Group | £m | £m |
Within one year | — | 0.4 |
After one year but not more than five years | — | — |
At 31 March | — | 0.4 |
2026 | 2025 | |
Group | £m | £m |
Investment property at fair value | ||
At 1 April | 122.3 | 82.7 |
Additions | 27.7 | 59.9 |
Disposals | (16.8) | (33.1) |
Fair value (loss) / gain | (1.8) | 12.8 |
At 31 March | 131.4 | 122.3 |
Group | Company | |||
2026 | 2025 | 2026 | 2025 | |
£m | £m | £m | £m | |
Trade and other receivables within structured entities | 93.3 | 181.8 | — | — |
controlled by the Group | ||||
Trade and other receivables excluding those held in structured entities controlled by the Group | 243.7 | 250.4 | 72.8 | 74.2 |
Prepayments | 10.3 | 10.6 | 6.0 | 5.7 |
Total current assets | 347.3 | 442.8 | 78.8 | 79.9 |
Trade and other receivables excluding those held in structured entities controlled by the Group | 105.1 | 29.3 | 17.2 | 11.1 |
Amounts owed by Group companies | — | — | 849.9 | 859.4 |
Total non-current assets | 105.1 | 29.3 | 867.1 | 870.5 |
Group | Company | |||
2026 | 2025 | 2026 | 2025 | |
£m | £m | £m | £m | |
Trade and other payables within structured entities | 326.1 | 340.4 | — | — |
controlled by the Group | ||||
Trade and other payables excluding those held in structured entities controlled by the Group | 189.9 | 218.9 | 7.7 | 11.1 |
Amounts owed to Group companies | — | — | 1,275.6 | 809.7 |
Total current trade and other payables | 516.0 | 559.3 | 1,283.3 | 820.8 |
Trade and other payables excluding those held in structured entities controlled by the Group | 50.7 | 50.3 | 0.4 | 0.2 |
Total non-current trade and other payables | 50.7 | 50.3 | 0.4 | 0.2 |
2026 | 2025 | |||||
Floating 1,2 | Fixed 1,2 | Total 1,2 | ||||
Floating | Fixed | Total | (restated) | (restated) | (restated) | |
Group | £m | £m | £m | £m | £m | £m |
Assets | ||||||
Interest-bearing financial assets (excluding investments in loans held in consolidated structured entities) 3 | 172.3 | 1,045.7 | 1,218.1 | 205.4 | 1,274.9 | 1,480.3 |
Cash and Cash equivalents (excluding cash and cash equivalents held in consolidated structured entities) | 781.7 | 199.7 | 981.4 | 539.3 | 65.5 | 604.8 |
Derivatives 3 | — | — | — | — | 3.9 | 3.9 |
Collateral assets held in consolidated structured entities 3 | 5,086.0 | 243.6 | 5,329.6 | 4,730.5 | 222.9 | 4,953.4 |
Cash and Cash equivalents held within consolidated structured entities | 434.0 | — | 434.0 | 255.4 | — | 255.4 |
Trade and other receivables within structured entities controlled by the Group 4 | 60.3 | — | 60.3 | 140.3 | — | 140.3 |
Liabilities | ||||||
Financial liabilities (excluding borrowings and loans held in consolidated structured entities) | — | (1,033.8) | (1,033.8) | — | (1,175.9) | (1,175.9) |
Lease liabilities | — | (64.7) | (64.7) | — | (71.9) | (71.9) |
Borrowings related to seed investments | (34.3) | (39.5) | (73.8) | (17.0) | (40.3) | (57.3) |
Derivatives 3 | — | — | — | — | (6.1) | (6.1) |
Liabilities of consolidated CLOs 3 | (5,053.3) | (125.3) | (5,178.6) | (4,529.4) | (113.8) | (4,643.2) |
Trade and other payables within structured entities controlled by the Group 5 | (189.0) | — | (189.0) | (115.9) | — | (115.9) |
1,257.7 | 225.7 | 1,483.4 | 1,208.6 | 159.2 | 1,367.8 |
| Contractual maturity analysis | |||||
| Less than one | More than five | ||||
year | One to two years | Two to five years | years | Total | |
As at 31 March 2026 | £m | £m | £m | £m | £m |
Financial liabilities | |||||
Private placements | 73.8 | 5.1 | 99.5 | — | 178.4 |
Listed notes and bonds | 454.7 | 10.9 | 458.6 | — | 924.2 |
Derivative financial instruments | 11.2 | — | — | — | 11.2 |
Lease liabilities | 10.6 | 10.2 | 27.8 | 14.3 | 62.9 |
Other financial liabilities | 27.7 | 13.7 | 34.4 | — | 75.8 |
Contractual liabilities of consolidated CLOs including trade payables (see note 20) 1 | 604.5 | 239.5 | 891.0 | 6,830.0 | 8,565.0 |
1,182.5 | 279.4 | 1,511.3 | 6,844.3 | 9,817.5 |
| Contractual maturity analysis | |||||
| Less than one | More than five | ||||
year | One to two years | Two to five years | years | Total | |
As at 31 March 2025 | £m | £m | £m | £m | £m |
Financial liabilities | |||||
Private placements | 190.2 | 73.8 | 107.1 | — | 371.1 |
Listed notes and bonds | 17.3 | 435.9 | 450.0 | — | 903.2 |
Derivative financial instruments | 19.6 | — | — | — | 19.6 |
Lease liabilities | 9.8 | 9.7 | 27.6 | 24.8 | 71.9 |
Other financial liabilities | 2.7 | 28.9 | 28.8 | — | 60.4 |
Contractual liabilities of consolidated CLOs including trade payables (see note 20) 1 | 604.5 | 610.0 | 1,003.9 | 4,864.3 | 7,082.7 |
844.1 | 1,158.3 | 1,617.4 | 4,889.1 | 8,508.9 |
| 2026 | |||||
| Net | |||||
| statement of | |||||
| financial | Forward | ||||
| position | exchange | Sensitivity to | Increase in | ||
| exposure | contracts | Net exposure | strengthening | net assets | |
Market risk - Foreign exchange risk | £m | £m | £m | % | £m |
Sterling | 757.5 | 1,501.7 | 2,259.2 | — | — |
Euro | 830.9 | (551.5) | 279.4 | 15% | 41.9 |
US dollar | 854.0 | (687.0) | 167.0 | 20% | 33.4 |
Other currencies | 269.8 | (274.4) | (4.6) | 10-25% | — |
2,712.2 | (11.2) | 2,701.0 | 75.3 |
| 2025 | |||||
| Net | |||||
| statement of | |||||
| financial | Forward | ||||
| position | exchange | Sensitivity to | Increase in | ||
| exposure | contracts | Net exposure | strengthening | net assets | |
£m | £m | £m | % | £m | |
Sterling | 482.2 | 1,503.3 | 1,985.5 | — | — |
Euro | 918.1 | (688.5) | 229.6 | 15% | 34.4 |
US dollar | 820.5 | (484.3) | 336.2 | 20% | 67.2 |
Other currencies | 258.1 | (312.6) | (54.5) | 10-25% | — |
2,478.9 | 17.9 | 2,496.8 | 101.6 |
| Number of ordinary | |||
| shares of 26¼p allotted, | Share Capital | Share Premium | |
Group and Company | called up and fully paid | £m | £m |
1 April 2025 | 294,370,225 | 77.3 | 181.3 |
Shares issued | 1,684,333 | 0.4 | 26.7 |
31 March 2026 | 296,054,558 | 77.7 | 208.0 |
| Number of ordinary | |||
| shares of 26¼p allotted, | Share Capital | Share Premium | |
Group and Company | called up and fully paid | £m | £m |
1 April 2024 | 294,365,326 | 77.3 | 181.3 |
Shares issued | 4,899 | 0.0 | — |
31 March 2025 | 294,370,225 | 77.3 | 181.3 |
2026 | 2025 | 2026 | 2025 | |
£m | £m | Number | Number | |
1 April | 103.9 | 79.2 | 7,985,888 | 7,666,863 |
Purchased - share scheme (ordinary shares of 26¼p) | 34.0 | 42.4 | 2,000,000 | 2,000,000 |
Purchased - share buyback (ordinary shares of | 44.0 | — | 2,785,365 | — |
26¼p) | ||||
Options/awards exercised | (35.8) | (17.7) | (1,943,901) | (1,680,975) |
As at 31 March | 146.1 | 103.9 | 10,827,352 | 7,985,888 |
Number | Weighted average fair value | |||
2026 | 2025 | 2026 | 2025 | |
Deferred share awards | £ | £ | ||
Outstanding at 1 April | 3,244,442 | 3,804,026 | 16.95 | 14.35 |
Granted | 1,189,006 | 1,141,054 | 20.45 | 23.11 |
Vested | (1,763,397) | (1,700,638) | 15.76 | 15.33 |
Outstanding as at 31 March | 2,670,051 | 3,244,442 | 19.19 | 16.95 |
Number | Weighted average fair value | |||
2026 | 2025 | 2026 | 2025 | |
PLC Equity awards | £ | £ | ||
Outstanding at 1 April | 2,992,342 | 2,614,058 | 17.00 | 14.70 |
Granted | 1,202,938 | 839,597 | 20.45 | 23.10 |
Vested | (630,104) | (461,313) | 15.29 | 14.90 |
Outstanding as at 31 March | 3,565,176 | 2,992,342 | 18.43 | 17.00 |
Number | Weighted average fair value | |||
2026 | 2025 | 2026 | 2025 | |
Buy Out Awards | £ | £ | ||
Outstanding as at 1 April | 445,446 | 809,303 | 13.74 | 13.41 |
Granted | 71,731 | 110,225 | 20.57 | 21.52 |
Vesting | (267,566) | (474,082) | 14.26 | 15.02 |
Outstanding as at 31 March | 249,611 | 445,446 | 15.14 | 13.74 |
| Weighted average exercise | ||||
| Number | value | |||
2026 | 2025 | 2026 | 2025 | |
Save As You Earn | £ | £ | ||
Outstanding as at 1 April | 180,082 | 222,121 | 10.91 | 11.57 |
Granted | 74,342 | — | 17.26 | — |
Exercised | (2,514) | (19,990) | 11.31 | 16.77 |
Forfeited | (28,457) | (22,049) | 12.42 | 12.26 |
Outstanding as at 31 March | 223,453 | 180,082 | 12.83 | 10.91 |
Exercisable at end | 1,719 | 2,751 | 10.79 | 16.99 |
| Weighted average exercise | ||||
| Number | value | |||
2026 | 2025 | 2026 | 2025 | |
Growth Incentive Award | £ | £ | ||
Outstanding as at 1 April | 389,000 | 411,000 | 14.27 | 14.27 |
Granted | 499,000 | — | 20.45 | — |
Exercised | (147,000) | — | 14.27 | — |
Forfeited | (12,000) | (22,000) | 14.27 | 14.27 |
Outstanding as at 31 March | 729,000 | 389,000 | 18.50 | 14.27 |
Exercisable at end | 230,000 | — | 14.27 | — |
2026 | 2025 | |
£m | £m | |
ICG Europe Fund V | 25.0 | 24.0 |
ICG Europe Fund VI | 79.0 | 78.0 |
ICG Europe Fund VII | 104.0 | 100.0 |
ICG Europe Fund VIII | 56.0 | 45.0 |
ICG Europe Fund IX | 313.0 | 148.0 |
ICG Mid-Market Fund | 13.0 | 13.0 |
ICG Mid-Market Fund II | 40.0 | 40.0 |
Intermediate Capital Asia Pacific Fund III | 58.0 | 59.0 |
ICG Asia Pacific Fund IV | 50.0 | 36.0 |
ICG Strategic Secondaries Fund II | 34.0 | 34.0 |
ICG Strategic Equity Fund III | 81.0 | 81.0 |
ICG Strategic Equity Fund IV | 36.0 | 38.0 |
ICG Strategic Equity Fund V | 49.0 | 62.0 |
ICG Recovery Fund II | 14.0 | 21.0 |
LP Secondaries | 25.0 | 30.0 |
LP Secondaries II | 38.0 | — |
Europe CPE Parallel | 19.0 | — |
ICG Senior Debt Partners 2 | 4.0 | 4.0 |
ICG Senior Debt Partners 3 | 5.0 | 5.0 |
ICG Senior Debt Partners 4 | 5.0 | 5.0 |
Senior Debt Partners 5 | 23.0 | 27.0 |
Senior Debt Partners NYCERS | 3.0 | 4.0 |
ICG North American Private Debt Fund | 23.0 | 26.0 |
ICG North American Private Debt Fund II | 20.0 | 21.0 |
ICG North American Credit Partners III | 55.0 | 69.0 |
ICG-Longbow UK Real Estate Debt Investments VI | 3.0 | 6.0 |
ICG Real Estate Debt VII | 15.0 | — |
ICG-Longbow Development Fund | — | 14.0 |
ICG Infrastructure Equity Fund I | 40.0 | 52.0 |
ICG Infrastructure Equity Fund II | 112.0 | 102.0 |
ICG Infrastructure APAC | 13.0 | — |
ICG Living | 20.0 | 21.0 |
ICG Private Markets Pooling - Sale & Leaseback | 17.0 | 17.0 |
ICG Sale & Leaseback II | 23.0 | 17.0 |
ICG Metropolitan II | 50.0 | 28.0 |
Multistrat SMAs | 1.0 | 2.0 |
1,466.0 | 1,229.0 |
2026 | 2025 | |
£m | £m | |
Income statement | ||
Net gains/(losses) on investments | (21.7) | (18.4) |
(21.7) | (18.4) |
2026 | 2025 | |
£m | £m | |
Statement of financial position | ||
Trade and other receivables | 16.0 | 47.5 |
Trade and other payables | — | (11.7) |
16.0 | 35.8 |
2026 | 2025 | |
£m | £m | |
Income statement | ||
Management fees | 664.7 | 580.6 |
Performance-related management fees | 133.5 | 87.4 |
Other income | 5.9 | 8.0 |
804.1 | 676.0 |
2026 | 2025 | |
£m | £m | |
Statement of financial position | ||
Performance fees receivable | 144.7 | 108.4 |
Trade and other receivables | 208.1 | 406.3 |
Trade and other payables | (267.2) | (491.8) |
85.6 | 22.9 |
2026 | 2025 | |
£m | £m | |
Short-term employee benefits | 4.4 | 3.9 |
Post-employment benefits | 0.2 | 0.3 |
Other long-term benefits | — | — |
Share-based payment benefits | 7.4 | 6.8 |
12.0 | 11.0 |
2026 | 2025 | |
£000 | £000 | |
William Rucker | 425.0 | 400.0 |
Andrew Sykes | 154.5 | 139.8 |
Rosemary Leith | 144.0 | 134.5 |
Matthew Lester | 127.0 | 120.5 |
Virginia Holmes | 127.0 | 120.5 |
Stephen Welton | 97.0 | 90.5 |
Amy Schioldager | — | 37.0 |
Sonia Baxendale | 114.0 | 26.1 |
Robin Lawther | 40.4 | — |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG Asset Management Limited (formerly ICG LTD) | United Kingdom | Holding company | Ordinary shares | 100% | |
ICG FMC Limited | England & Wales | Holding company | Ordinary shares | 100% | |
Intermediate Capital Investments Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG Global Investment UK Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG Carbon Funding Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG Longbow Richmond Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG-Longbow BTR Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG Longbow Development (Brighton) Limited | England & Wales | Holding company | Ordinary shares | 100% | |
LREC Partners Investments No. 2 Limited | England & Wales | Investment company | Ordinary shares | 55% | |
ICG Longbow Senior Debt I GP Limited | England & Wales | General partner | Ordinary shares | 100% | |
ICG Debt Advisors (Cayman) Ltd | 4 | Cayman Islands | Advisory company | Ordinary shares | 100% |
ICG Re Holding (Germany) GmbH | 10 | Germany | Special purpose vehicle | Ordinary shares | 100% |
ICG Watch Jersey GP Limited | 19 | Jersey | General partner | Ordinary shares | 100% |
Intermediate Capital Group Espana SL | 37 | Spain | Advisory company | Ordinary shares | 100% |
ICG Co-Investment 2024 Plus Limited | England & Wales | Investment company | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
Australia Re Funding Co PTE. Ltd | 31 | Singapore | General Partner | Ordinary shares | 100% |
Bronte GP I S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
Bronte GP LP SCSp | 21 | Luxembourg | Limited Partner | N/A | —% |
ICG - Longbow Fund V GP S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG (DIFC) Limited | 40 | United Arab Emirates | Service company | Ordinary shares | 100% |
ICG Alternative Credit (Cayman) GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Alternative Credit (Jersey) GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Alternative Credit (Luxembourg) GP S.A. | 24 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Alternative Credit LLC | 44 | United States of America | Advisory company | Ordinary shares | 100% |
ICG Alternative Investment (Netherlands) B.V. | 28 | Netherlands | Advisory company | Ordinary shares | 100% |
ICG Alternative Investment Limited | England & Wales | Advisory company | Ordinary shares | 100% | |
ICG Asia Pacific Fund III GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Asia Pacific Fund III GP Limited Partnership | 19 | Jersey | Limited Partner | N/A | —% |
ICG Asia Pacific Fund IV GP LP SCSp | 25 | Luxembourg | Limited Partner | N/A | —% |
ICG Asia Pacific Fund IV GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Asia Pacific Limited (formerly Intermediate Capital Asia Pacific Limited) | 13 | Hong Kong | Advisory company | Ordinary shares | 100% |
ICG Assetmark Preferred Aggregator GP LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
ICG Augusta Associates LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Augusta GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Australian Senior Debt GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Centre Street Partnership GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG Core Private Equity GP LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Core Private Equity GP LP SCSp | 21 | Luxembourg | Limited Partner | N/A | —% |
ICG Core Private Equity GP S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG CPE Europe GP LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG CPE Europe GP S.a.r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Debt Administration LLC | 44 | United States of America | Service company | Ordinary shares | 100% |
ICG Debt Advisors LLC – Holdings Series | 44 | United States of America | Investment company | Ordinary shares | 100% |
ICG Debt Advisors LLC - Manager Series | 44 | United States of America | Advisory company | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG EFV MLP GP LIMITED | England & Wales | General Partner | Ordinary shares | 100% | |
ICG EFV MLP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG Employee Benefit Trust 2015 | 12 | Guernsey | N/A | Ordinary shares | 100% |
ICG Enterprise Carry GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Enterprise Co-Investment GP Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG Europe Amsterdam, Branch of ICG Europe S.à r.l. | 28 | Netherlands | Branch | Ordinary shares | 100% |
ICG Europe Copenhagen, filial af ICG Europe S.à r.l. | 6 | Denmark | Branch | N/A | 100% |
ICG Europe Fund IX GP LP SCSp | 26 | Luxembourg | General Partner | N/A | —% |
ICG Europe Fund IX GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Fund V GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG Europe Fund V GP Limited Partnership | 18 | Jersey | Limited Partner | N/A | —% |
ICG Europe Fund VI GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG Europe Fund VI GP Limited Partnership | 18 | Jersey | Limited Partner | N/A | —% |
ICG Europe Fund VI Lux GP S.à r.l. | 20 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Fund VII GP LP SCSp | 26 | Luxembourg | Limited Partner | N/A | —% |
ICG Europe Fund VII GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Fund VIII GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Europe Fund VIII GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Mid-Market Fund GP LP SCSp | 26 | Luxembourg | Limited Partner | N/A | —% |
ICG Europe Mid-Market Fund GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Mid-Market Fund II GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe S.a r.l. | 22 | Luxembourg | Advisory company | Ordinary shares | 100% |
ICG Europe SARL - Frankfurt Branch | 11 | Germany | Branch | N/A | 100% |
ICG Europe SARL - Milan Branch | 14 | Italy | Branch | N/A | 100% |
ICG Europe SARL - Paris Branch | 9 | France | Branch | N/A | 100% |
ICG European Credit Mandate GP LP SCSp | 26 | Luxembourg | Limited Partner | N/A | —% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG European Credit Mandate GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG European Fund 2006 B GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG EXCELSIOR GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Excelsior GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Fund Advisors LLC | 44 | United States of America | Advisory company | Ordinary shares | 100% |
ICG Global Investment Jersey Limited | 17 | Jersey | Investment company | Ordinary shares | 100% |
ICG Global Nominee Jersey Limited | 17 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Infrastructure APAC I GP LP SCSp | 21 | Luxembourg | Limited Partner | N/A | —% |
ICG Infrastructure APAC I GP S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Infrastructure Equity Fund I GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Infrastructure Equity Fund I GP S.a.r.l | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Infrastructure Fund II GP S.à r.l | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG International Holdco Inc. | 41 | United States of America | Advisory company | Ordinary shares | 100% |
ICG Investments Inc. (formerly Intermediate Capital Group Inc.) | 44 | United States of America | Advisory company | Ordinary shares | 100% |
| ICG Investments Singapore Pte. Limited (formerly Intermediate Capital | 30 | Singapore | Advisory company | Ordinary shares | 100% |
| Group (Singapore) Pte. Limited) | |||||
ICG Japan KK | 16 | Japan | Advisory company | Ordinary shares | 100% |
ICG Life Sciences GP LP SCSp | 25 | Luxembourg | Limited Partner | N/A | —% |
ICG Life Sciences GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Life Sciences SCSp | 25 | Luxembourg | Limited Partner | N/A | —% |
ICG Living GP S.a r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Longbow Development Debt Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG LP Secondaries Associates I LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Associates II GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG LP Secondaries Associates II LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Fund Associates I S.a. r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Fund Associates II S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Fund II GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG LP Secondaries I GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Manager Limited (formerly Intermediate Capital Managers Limited) | England & Wales | Advisory company | Ordinary shares | 100% | |
ICG Metropolitan GP S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Nordic AB | 38 | Sweden | Advisory company | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG North America Associates II LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
ICG North America Associates III - Preferred Equity GP LP | 44 | United States of America | Limited Partner | N/A | —% |
ICG North America Associates III - Preferred Equity LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
ICG North America Associates III LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
ICG North America Associates III S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG North America Associates LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
ICG North American Private Debt (Offshore) GP Limited Partnership | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG North American Private Debt GP LP | 44 | United States of America | Limited Partner | N/A | —% |
ICG North American Private Debt II (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG North American Private Debt II GP LP | 44 | United States of America | Limited Partner | N/A | —% |
ICG Private Credit GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Private Markets General Partner SCSp | 25 | Luxembourg | General Partner | N/A | —% |
ICG Private Markets GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG RE Australia Group PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
ICG RE Capital Partners Australia PTY LTD | 3 | Australia | Advisory company | Ordinary shares | 100% |
ICG RE Corporate Australia PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
ICG RE Funds Management Australia PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
ICG Real Estate Debt VI GP LP SCSp | 25 | Luxembourg | Limited Partner | N/A | —% |
ICG Real Estate Debt VI GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Debt VII GP LP SCSp | 21 | Luxembourg | Limited Partner | N/A | —% |
ICG Real Estate Debt VII GP Sarl | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Multi-Strategy GP I S.à r.l | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Opportunities APAC GP S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Senior Debt V GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Recovery Fund 2008 B GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Recovery Fund II GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Recovery Fund II GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG RED Dart GP Sarl | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG RED Dart GPLP SCSp | 21 | Luxembourg | Limited Partner | N/A | —% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG SEMM General Partner S.a r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG SEMM GP LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG SEMM GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG SEMM GP SCSp | 27 | Luxembourg | General Partner | N/A | —% |
ICG Senior Debt Partners | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners Co Invest X GP LP SCSp | 26 | Luxembourg | Limited Partner | N/A | —% |
ICG Senior Debt Partners Co Invest X GP S.à r.l. | 26 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners GP S.à r.l. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners UK GP Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG SRE GP II S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG SRE GP III S.à r.l. | 21 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Advisors LLC | 44 | United States of America | Advisory company | Ordinary shares | 100% |
ICG Strategic Equity Associates II LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Associates III LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Associates IV LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Associates IV S.à r.l | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity GP V LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Strategic Equity GP V S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity III (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Strategic Equity III GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Strategic Equity IV GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Strategic Equity IV GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | —% |
ICG Strategic Equity Side Car (Onshore) GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Strategic Equity Side Car GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Strategic Equity Side Car II (Onshore) GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Strategic Equity Side Car II GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Strategic Secondaries Carbon (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Strategic Secondaries Carbon Associates LLC | 44 | United States of America | General Partner | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
ICG Strategic Secondaries II (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Strategic Secondaries II GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Structured Special Opportunities GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Switzerland GMBH | 39 | Switzerland | General Partner | Ordinary shares | 100% |
ICG Total Credit (Global) GP, S.à r.l. | 23 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG US Mid-Market Fund I LLC | 42 | United States of America | General Partner | Ordinary shares | 100% |
ICG Velocity Co-Investor (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | —% |
ICG Velocity Co-Investor Associates LLC | 43 | United States of America | General Partner | Ordinary shares | 100% |
ICG Velocity Co-Investor GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG Velocity GP LP | 43 | United States of America | Limited Partner | N/A | —% |
ICG-Longbow B Investments L.P. | England & Wales | Investment company | N/A | —% | |
ICG-Longbow Development GP LLP | England & Wales | General Partner | N/A | —% | |
ICG-Longbow IV GP S.à r.l. | 20 | Luxembourg | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific 2008 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific Mezzanine 2005 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific Mezzanine Opportunity 2005 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Australia PTY Limited | 1 | Australia | Advisory company | Ordinary shares | 100% |
Intermediate Capital GP 2003 Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital GP 2003 No.1 Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Group (Italy) S.R.L. | 14 | Italy | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group Benelux B.V. | 28 | Netherlands | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group Beratungsgesellschaft mbH | 10 | Germany | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group Dienstleistungsgesellschaft mbH | 10 | Germany | Service company | Ordinary shares | 100% |
Intermediate Capital Group Polska Sp. z.o.o | 29 | Poland | Service company | Ordinary shares | 100% |
Intermediate Capital Group SAS | 9 | France | Advisory company | Ordinary shares | 100% |
Intermediate Capital Managers (Australia) PTY Limited | 2 | Australia | Advisory company | Ordinary shares | 100% |
Intermediate Capital Managers (Australia) Pty Ltd Korea Branch | 36 | South Korea | Branch | Ordinary shares | 100% |
Longbow Real Estate Capital LLP | 8 | England & Wales | Advisory company | N/A | —% |
Wise Living Amber Langley Mill Limited | 7 | England & Wales | Special purpose vehicle | Ordinary shares | 83% |
Wise Living Homes Limited | 7 | England & Wales | Special purpose vehicle | Ordinary shares | 83% |
% Voting rights | |||||
Name | Ref 1 | Country of incorporation | Principal activity | Share class | held |
Capstone Living and Stay General Private Investment Company No. 1 | 32 | South Korea | Special purpose vehicle | Ordinary shares | 100% |
Capstone Living and Stay General Private Investment Company No. 2 | 35 | South Korea | Special purpose vehicle | Ordinary shares | 100% |
Godo Kaisha Co-living One | 15 | Japan | Special purpose vehicle | Ordinary shares | 100% |
Godo Kaisha Converse | 15 | Japan | Special purpose vehicle | Ordinary shares | 100% |
ICG Core Private Equity Fund LP | 43 | United States of America | Special purpose vehicle | N/A | —% |
ICG Core Private Equity Master LP | 43 | United States of America | Special purpose vehicle | N/A | —% |
ICG Funding Lux S.à r.l. | 21 | Luxembourg | Special purpose vehicle | Ordinary shares | 100% |
ICG Life Sciences Debt Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Life Sciences Feeder SCSp | 25 | Luxembourg | Special purpose vehicle | N/A | —% |
ICG North American Private Equity Debt (Jersey) Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Real Estate Opportunities APAC Fund SCSp | 21 | Luxembourg | Special purpose vehicle | N/A | —% |
ICG Seed Asset Founder LP Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG-Longbow Investment 3 LLP | England & Wales | Special purpose vehicle | N/A | —% | |
IGISX General Real Estate Private Investment Company No.12 | 34 | South Korea | Special purpose vehicle | Ordinary shares | 100% |
Montero Cruise JP 1 Pte. Ltd | 31 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Cruise JP 2 Pte. Ltd | 31 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Japan Master Pte. Ltd | 31 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Pte. Ltd. | 31 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Rifa Private Real Estate Trust No. 24 | 33 | South Korea | Special purpose vehicle | Ordinary shares | 100% |
Tokutei Mokutei Co-living One | 15 | Japan | Special purpose vehicle | Ordinary shares | 100% |
Tokutei Mokutei Converse | 15 | Japan | Special purpose vehicle | Ordinary shares | 100% |
Yangju Investment PTE. Limited | 31 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
| Registered offices | |
1 | Level 18, 88 Phillip Street, Sydney, NSW 2000, Australia |
2 | Level 31, 88 Phillip Street, Sydney, NSW 2000, Australia |
3 | Level 9, 88 Phillip Street, Sydney, NSW 2000, Australia |
4 | 75 Fort Street, Clifton House, c/o Estera Trust (Cayman) Limited, PO Box 1350, Grand Cayman, |
KY1-1108, Cayman Islands | |
5 | PO Box 309, Ugland House, C/o Maples Corporate Services Limited, Grand Cayman, KY1-1104, |
Cayman Islands | |
6 | Female Founders House Bredgade 45B, 3., kontor, Copenhagen, 607 1260, Denmark |
7 | 17 Regan Way, Chetwynd Business Park, Chilwell, Nottingham, NG9 6RZ, England & Wales |
8 | 25 Farringdon Street, London, EC4A 4AB |
9 | 1 rue de la Paix, Paris, 75002, France |
10 | 12th Floor, An der Welle 5, Frankfurt, 60322, Germany |
11 | 12th Floor, Stockwerk, An der Welle 5, Frankfurt, 60322, Germany |
12 | c/o Zedra Trust Company (Guernsey) Limited, 3rd Floor, Cambridge House, Le Truchot, St Peter Port, |
GY1 1WD, Guernsey | |
13 | Suites 1301-02, 13/F, AIA Central, 1 Connaught Road Central, Hong Kong |
14 | Corso Giacomo Matteotti 3, CAP 20121 Milano, Italy |
15 | 1-1-7-807 Motoakasaka, Minato-ku, Tokyo, Japan, |
16 | Level 23, Otemachi Nomura Building, 2-1-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan |
17 | 6 Esplanade, St. Helier, JE1 1BX, Jersey |
18 | IFC 1, The Esplanade, St. Helier, JE1 4BP, Jersey |
19 | Ogier House,44 The Esplanade, St. Helier, JE4 9WG, Jersey |
20 | 12E, rue Guillaume Kroll, L - 1882 Luxembourg |
21 | 3, rue Gabriel Lippmann, L - 5365 Munsbach, Luxembourg |
22 | 32-36, boulevard d'Avranches L - 1160 Luxembourg, 1160, Luxembourg |
23 | 49 Avenue John F. Kennedy, Luxembourg, L-1855, Luxembourg |
24 | 5 Allée Scheffer, Luxembourg, L-2520, Luxembourg |
25 | 6, rue Eugene Ruppert, Luxembourg, L-2453, Luxembourg |
| Registered offices | |
26 | 60, Avenue J.F. Kennedy, Luxembourg, L-1855, Luxembourg |
27 | 6H Route de Trèves, Senningerberg, L-2633, Luxembourg |
28 | Paulus Potterstraat 20, 2hg., Amsterdam, 1071 DA, Netherlands |
29 | Spark B, Aleja Solidarności 171, Warsaw, 00-877, Poland |
30 | 8 Marina View, #32-06. Asia Square Tower 1, 018960, Singapore |
31 | 9 Temasek Boulevard, #12-01/02. Suntec Tower Two, 038989, Singapore |
32 | 116, Ingye-ro, Paldal-gu, Suwon-si, Gyeonggi-do, Republic of Korea |
33 | 12F, 136, Sejong-daero, Jung-gu, Seoul, Republic of Korea |
34 | 136, Sejong-daero, Jung-gu, Seoul, Republic of Korea |
35 | 182, Beotkkot-ro, Geumcheon-gu, Seoul, Republic of Korea |
36 | 29F, Parnas Tower, 521 Teheran-ro, Gangnam-gu, Seoul, Republic of Korea |
37 | Serrano 30-3º, 28001 Madrid, Spain |
38 | David Bagares Gata 3, 111 38 Stockholm |
39 | Bleicherweg 10, 8002 Zürich, Switzerland |
40 | Index Tower, Floor 4, Unit 404, Dubai International Financial Centre, Dubai, United Arab Emirates |
41 | c/o Corporation Service Company, 251 Little Falls Drive, Wilmington, DE, 19801, United States of |
America | |
42 | c/o Intertrust Corporate Services Delaware LTD, Suite 210, 200 Bellevue Parkway, Wilmington, DE, |
United States of America | |
43 | c/o Maples Fiduciary Services (Delaware) Inc., Suite 302, 4001 Kennett Pike, Wilmington, DE, 19807, |
United States of America | |
44 | c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, DE, 19801, United States of |
America |
Name of subsidiary | Country of incorporation | % of ownership interests and voting rights |
| ICG US CLO 2014-1, Ltd. | Cayman Islands | 50% |
| ICG US CLO 2014-2, Ltd. | Cayman Islands | 72% |
| ICG US CLO 2014-3, Ltd. | Cayman Islands | 51% |
| ICG US CLO 2015-1, Ltd. | Cayman Islands | 50% |
| ICG US CLO 2015-2R, Ltd. | Cayman Islands | 83% |
| ICG US CLO 2016-1, Ltd. | Cayman Islands | 63% |
| ICG US CLO 2017-1, Ltd. | Cayman Islands | 60% |
| ICG US CLO 2020-1, Ltd. | Cayman Islands | 52% |
| ICG EURO CLO 2021-1 DAC | Ireland | 67% |
| ICG EURO CLO 2023-2 DAC | Ireland | 100% |
| St. Paul's CLO II DAC | Ireland | 85% |
| St. Paul's CLO III-R DAC | Ireland | 62% |
| St. Paul's CLO VI DAC | Ireland | 53% |
| St. Paul's CLO VIII DAC | Ireland | 53% |
| St. Paul's CLO XI DAC | Ireland | 57% |
| ICG Euro CLO 2023-1 DAC | Ireland | 100% |
| ICG Enterprise Carry (1) LP | Jersey | 100% |
| ICG Enterprise Carry (2) LP | Jersey | 50% |
| ICG Total Credit (Global) SCA | Luxembourg | 100% |
| ICG EURO CLO 2024-1 DAC | Ireland | 100% |
| ICG US CLO 2024-1, Ltd. | Cayman Islands | 100% |
| ICG US CLO 2024-R1, Ltd. | Cayman Islands | 100% |
| ICG US CLO 2021-1, Ltd. | Cayman Islands | 56% |
| ICG US CLO 2025-1, Ltd. | Cayman Islands | 100% |
| ICG EURO CLO 2025-1 DAC | Ireland | 85% |
| ICG US CLO 2025-2, Ltd. | Cayman Islands | 100% |
Company | Registered number | Member(s) |
ICG FMC Limited | 7266173 | ICG plc |
ICG Global Investment UK Limited | 7647419 | ICG plc |
ICG Longbow Development (Brighton) | ||
Limited | 8802752 | ICG plc |
ICG Longbow Richmond Limited | 11210259 | ICG plc |
ICG Longbow BTR Limited | 11177993 | ICG plc |
ICG Longbow Senior Debt I GP Limited | 2276839 | ICG plc |
Intermediate Capital Investments Limited | 2327070 | ICG plc |
LREC Partners Investments No. 2 Limited | 7428335 | ICG plc |
ICG Asset Management Limited (formerly | ||
ICG Ltd) | 14542130 | ICG plc |
ICG-Longbow Development GP LLP | OC396833 | ICG plc, ICG FMC Limited |
ICG-Longbow Investment 3 LLP | OC395389 | ICG FMC Limited, |
| ICG Manager Limited | ||
ICG Enterprise Co-Investment GP Limited | 9961033 | ICG plc, ICG FMC Limited |
ICG EFV MLP GP Limited | 7758327 | ICG EFV MLP Ltd |
ICG Senior Debt Partners UK GP Limited | 8562977 | ICG plc, ICG FMC Limited |
ICG Co-Investment 2024 Plus Limited | 16107851 | ICG plc |
| Proportion of ownership interest/ | Income distributions received | Proportion of ownership interest/ | Income distributions received | |||
| voting rights held by the Group | from associate | voting rights held by the Group | from associate | |||
| 2026 | 2026 | 2025 | 2025 | |||
Name of associate | Principal activity | Country of incorporation | £m | £m | ||
ICG Europe Fund V Jersey Limited 1 | Investment company | Jersey | 20% | 14.1 | 20% | — |
ICG Europe Fund VI Jersey Limited 1 | Investment company | Jersey | 17% | 39.6 | 17% | 56.8 |
ICG North American Private Debt Fund 2 | Investment company | United States of America | 20% | 1.6 | 20% | 1.8 |
ICG Asia Pacific Fund III Singapore Pte. Limited 3 | Investment company | Singapore | 20% | 23.3 | 20% | 1.3 |
KIK Equity Co-invest LLC 2 | Investment company | United States of America | 25% | — | 25% | — |
Seaway Topco, LP 2 | Investment company | United States of America | 49% | — | 49% | — |
| Proportion of ownership | Proportion of voting | ||||
| interest held by the | rights held by the Group | ||||
Name of joint venture | Accounting method | Principal activity | Country of incorporation | Group 2026 | 2026 |
| Investment | |||||
Brighton Marina Group Limited | Fair value | company | United Kingdom | 70% | 50% |
| ICG Fund VI Jersey Limited | ||
2026 | 2025 | |
£m | £m | |
Current assets | 0.7 | 358.1 |
Non-current assets | 210.8 | 952.6 |
Current liabilities | — | (357.7) |
211.5 | 953.0 | |
Revenue | (71.3) | 343.1 |
Expenses | (0.2) | (0.2) |
Total comprehensive income | (71.5) | 342.9 |
| 2026 | ||||||
| Investment in | Management fees | Performance fees | Maximum | |||
| Fund | receivable | Management fee rates | receivable | Performance fee rates | exposure to loss | |
Funds | £m | £m | % | £m | % | £m |
Structured Capital and Secondaries | 1,601.5 | 92.5 | 0.25% to 1.38% | 112.5 | 20%–25% of total performance fee of 10%–20% of profit over the threshold | 1,806.5 |
Real Assets | 356.8 | 37.2 | 0.03% to 1.23% | 8.2 | 20% of total performance fee of 15%–20% of profit over the threshold | 402.2 |
Debt | 433.8 | 40.5 | 0.33% to 1.50% | 24.1 | 20% of returns in excess of 0% for Alternative Credit Fund only and IRR of 12% | 498.4 |
| for CLOs | ||||||
Total | 2,392.1 | 170.2 | 144.8 | 2,707.1 |
| 2025 | ||||||
| Investment in | Management fees | Performance fees | Maximum | |||
| Fund | receivable | Management fee rates | receivable | Performance fee rates | exposure to loss | |
Funds | £m | £m | % | £m | % | £m |
Structured Capital and Secondaries | 1,823.8 | 86.4 | 0.25% to 1.38% | 102.6 | 20%–25% of total performance fee of 10%–20% of profit over the threshold | 2,012.8 |
Real Assets | 442.7 | 21.8 | 0.03% to 1.23% | — | 20% of total performance fee of 15%–20% of profit over the threshold | 464.5 |
Debt | 384.8 | 28.3 | 0.29% to 1.50% | 5.8 | 20% of returns in excess of 0% for Alternative Credit Fund only and IRR of 12% | 418.9 |
| for CLOs | ||||||
Total | 2,651.3 | 136.5 | 108.4 | 2,896.2 |